Subscribe
shutterstock_664142593_jonathan_weiss-1
Jonathan Weiss / Shutterstock.com
13 August 2019AmericasSarah Morgan

Fed Circ affirms Eli Lilly victories over cancer drugs

The US Court of Appeals for the Federal Circuit last week affirmed two findings that Dr Reddy’s and Hospira had infringed Eli Lilly’s cancer drug Alimta (pemetrexed).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More on this story

Big Pharma
Eli Lilly and Eagle Pharma settle antitrust and infringement claims
18 December 2019   US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Americas
SCOTUS refuses to hear Eli Lilly patent win
16 June 2020   The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira.
Americas
Eli Lilly seals $1bn genetics deal
17 December 2020   Eli Lilly is expanding its genetics business with the $880 million purchase of Prevail Therapeutics, in a deal that could rise to more than $1 billion.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility